|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
4P50CA094056-16
|
$1,286,033
|
$154,324
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$40,777
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
|
5R21CA198776-02
|
$168,563
|
$168,563
|
CHOI, SUNG
|
UNIVERSITY OF MICHIGAN
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-03
|
$323,700
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$127,098
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$1,200
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$3,969
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$9,987
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
$124,198
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$35,347
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
|
4R01CA168814-04
|
$324,148
|
$324,148
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-32
|
$592,471
|
$592,471
|
PRESS, OLIVER
|
UNIVERSITY OF WASHINGTON
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-02
|
$2,373,000
|
$142,380
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
5F31CA196231-02
|
$30,096
|
$15,048
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-04
|
$327,850
|
$163,925
|
CHEN, JIANJUN
|
UNIVERSITY OF CINCINNATI
|
|
The impact of aging-associated chronic inflammation on the selection for oncogenic driver mutations in hematopoietic stem cells
|
1F30CA210383-01
|
$30,921
|
$15,461
|
HIGA, KELLY
|
UNIVERSITY OF COLORADO DENVER
|
|
The Genetics of Post-Transplant Relapse in Myeloid Malignancy
|
4R01CA175008-04
|
$365,200
|
$365,200
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
|
4R01CA166794-05
|
$309,342
|
$309,342
|
SERODY, JONATHAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$504,571
|
$252,285
|
Fowler, Daniel
|
CCR (NCI)
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
4K08CA169485-04
|
$171,372
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
5R01CA184728-02
|
$401,456
|
$401,456
|
CAO, XUEFANG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-02
|
$356,850
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses
|
1R21CA202358-01A1
|
$245,900
|
$245,900
|
CAO, XUEFANG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-08
|
$560,424
|
$280,212
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML
|
5K01CA188151-02
|
$169,020
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
T cell Development and Regeneration
|
ZIA BC 011633
|
$1,070,688
|
$1,070,688
|
Bhandoola, Avinash
|
CCR (NCI)
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$403,118
|
$302,339
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema
|
1R21CA201940-01A1
|
$171,459
|
$85,730
|
HU, MICKEY
|
STANFORD UNIVERSITY
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-03
|
$106,075
|
$106,075
|
ZAIA, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stanford Cancer Institute
|
2P30CA124435-09
|
$3,345,301
|
$133,812
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$109,325
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
SBIR TOPIC 342 - DIRECT TO PHASE II SBIR CONTRACT - A WEARABLE SYSTEM FOR ASSESSMENT OF FALL RISK ASSOCIATED WITH CANCER TREATMENT; PERIOD OF PERFORMANCE: 09/19/2016 - 09/18/2018.
|
261201600067C
|
$1,457,589
|
$728,795
|
EL-GOHARY, MAHMOUD
|
APDM, INC.
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S1
|
$131,625
|
$5,265
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S2
|
$118,659
|
$4,746
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S3
|
$99,902
|
$3,996
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S4
|
$199,940
|
$7,998
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S5
|
$447,972
|
$17,919
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S6
|
$31,320
|
$1,253
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S7
|
$749,842
|
$29,994
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
5P30CA016056-39
|
$4,021,233
|
$160,849
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Role of noncoding RNA in Regulating GVHD
|
4R01CA173878-04
|
$322,663
|
$322,663
|
REDDY, PAVAN
|
UNIVERSITY OF MICHIGAN
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-03
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S1
|
$60,000
|
$2,400
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S2
|
$114,211
|
$4,568
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S3
|
$125,000
|
$5,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
4P30CA006973-53
|
$6,995,267
|
$279,811
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
5R01CA183560-04
|
$500,000
|
$500,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer
|
1R01CA201788-01A1
|
$699,411
|
$699,411
|
POLLOCK, BRAD
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
Total relevant funding to Bone Marrow Transplantation for this search: $42,107,927
|